Harrick Scientific Products specializes in designing and manufacturing instruments for optical spectroscopy. Since being established in 1969, Harrick Scientific has advanced the frontiers of optical spectroscopy through its innovations in all spectroscopic techniques. The founder of the company, Dr. N.J. Harrick, pioneered attenuated total reflection (ATR) spectroscopy and became the principal developer of this technique. Harrick Scientific offers a complete selection of sampling accessories, including both standard and custom designs, as well as an extensive line of optical elements.
Harrick Scientific serves analytical markets worldwide. Harrick's customers typically are from research or quality control laboratories of industrial, governmental, research, and academic institutions throughout the world. Industries served include chemical, electronic, pharmaceutical, forensics, and biomedical.
Harrick Scientific offers the most complete line of spectroscopy sampling products, including:
Harrick Scientific Products is located 30 miles north of New York City in Pleasantville, New York. Our products are also available through FT-IR and UV–vis spectrometer manufacturers, as well as distributors in the United States and throughout the world.
Harrick Scientific Products, Inc.
141 Tompkins Ave,
2nd Floor
Pleasantville, NY 10570
TELEPHONE
(800) 248-3847
FAX
(914) 747-7209
E-MAILinfo@harricksci.com
WEB SITEwww.harricksci.com
NUMBER OF EMPLOYEES
25
YEAR FOUNDED
1969
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.